Immune abnormalities linked to lung inflammation and damage in people with cystic fibrosis (CF) may begin early in life…
Articles by Michela Luciano, PhD
Immune cells that patrol the lungs, called alveolar macrophages, may help sustain persistent inflammation in cystic fibrosis (CF), according…
Having a family history of diabetes may significantly increase the risk of developing cystic fibrosis-related diabetes (CFRD), a common…
The U.S. Food and Drug Administration (FDA) has expanded the approvals of two Vertex Pharmaceuticals therapies to include additional mutations…
Agena Bioscience has launched a new genetic testing panel designed to detect a broader range of mutations that cause…
American Airlines and its partners have raised more than $1.6 million for the Cystic Fibrosis Foundation (CFF) during…
Antiverse has entered into a research collaboration with the Cystic Fibrosis Foundation to develop novel antibodies targeting CFTR,…
A smoking cessation program designed specifically for families of children with cystic fibrosis (CF) helped caregivers better understand the harms…
Treatment with Trikafta (elexacaftor/tezacaftor/ivacaftor) may do more than improve the function of a faulty protein in people with…
Levels in the bloodstream of certain circulating microRNAs — small strands of genetic material that help regulate gene activity —…